Thai PM, Cabinet cancel scheduled AstraZeneca vaccinations
Thailand's Prime Minister Prayut Chan-o-cha and members of his cabinet cancelled on Friday plans to receive AstraZeneca vaccine shots after the country delayed use of the vaccines over reports of blood clots in some European nations, a health official said.
BANGKOK: Thailand's Prime Minister Prayut Chan-o-cha and members of his Cabinet cancelled on Friday (Mar 12) plans to receive AstraZeneca vaccine shots after the country delayed use of the vaccines over reports of blood clots in some European nations, a health official said.
In a health ministry news conference, Prasit Watanapa, dean of the Faculty of Medicine at Siriraj Hospital, confirmed that the roll-out would be delayed after a suspension of inoculations using the vaccine in Denmark, Norway and Iceland.
Denmark suspended the shots for two weeks after a 60-year-old woman, who was given an AstraZeneca shot from the same batch used in Austria, formed a blood clot and died, Danish health authorities said.
Their response was also prompted by reports "of possible serious side effects" from other European countries.
Norway and Iceland said the suspension was a precaution.
"Though the quality of AstraZeneca is good, some countries have asked for a delay," said Piyasakol Sakolsatayadorn, an adviser for Thailand's COVID-19 vaccine committee, in a press conference.
"We will delay (as well)."
Thailand was in a position to suspend the rollout for safety investigations because it had brought under control a second wave of coronavirus cases, said Kiattiphum Wongjit, permanent secretary for the Public Health Ministry.
Yong Poonvorawan, a virology expert, told the news conference that the investigation would also check on whether any issues might be related to particular batches in Europe and said the vaccines supplied to Thailand were made in Asia.
Thailand has so far recorded just over 26,500 coronavirus infections and 85 fatalities in a population of 66.5 million. A second wave that began in December is now registering below 100 new infections per day.
Thailand's overall vaccination strategy is heavily reliant on AstraZeneca, which will be produced locally by a company owned by the country's king, with 61 million doses reserved for the Thai population.
However, the locally made AstraZeneca is not due to be ready until at least June, and Thailand last week began limited inoculations with imported doses of the Sinovac vaccine.
Thailand has so far administered about 40,000 of the 200,000 recently received doses of Sinovac’s CoronaVac, Kiattiphum said.
The country also last week received 117,300 doses of the AstraZeneca vaccine, which the prime minister and his Cabinet had been scheduled to receive on Friday.
Kiattiphum said that Thailand's imported doses were not from the same batch that is being investigated in Europe.
"We got this from global supply and there is no report of this (problem) in Asia," he said.